Last reviewed · How we verify
NCT05406947
Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children
trial testing Prospective observational study, no intervention in Medulloblastoma, Childhood in 350 participants. Not yet recruiting.
31 December 2028
Quick facts
| Lead sponsor | Beijing Tiantan Hospital |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 350 |
| Start date | 30 January 2023 |
| Primary completion | 31 December 2028 |
| Estimated completion | 31 December 2030 |
Drugs / interventions tested
- Prospective observational study, no intervention
Conditions studied
- Medulloblastoma, Childhood — all drugs for Medulloblastoma, Childhood →
Sponsor
Beijing Tiantan Hospital
Who can join
Adults 6 Months to 18, any sex, with Medulloblastoma, Childhood. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study:(1) Development of a new risk classification model for childhood medulloblastoma. (2) Evaluation and improvement of existing individualized treatment protocols.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05406947
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Medulloblastoma, Childhood
Currently open trials in the same condition.
- NCT06942039 — Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation · EARLY_PHASE1 · recruiting
- NCT06959979 — Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma · EARLY_PHASE1 · recruiting
- NCT06193759 — Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT) · Phase 1 · recruiting
- NCT05230758 — Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour · Phase 3 · recruiting
- NCT05057702 — Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma · NA · recruiting
Other Beijing Tiantan Hospital trials
Trials by the same sponsor.
- NCT07341854 — Dexamethasone Palmitate for Postoperative Pain · NA · not yet recruiting
- NCT07527013 — Stratified Blood Pressure Management Strategy After Endovascular Treatment for Acute Ischemic Stroke · Phase 3 · not yet recruiting
- NCT07520370 — Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain Tumor · NA · not yet recruiting
- NCT07526987 — Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis · Phase 3 · not yet recruiting
- NCT07591207 — The Efficacy and Safety of Loxoprofen Sodium Patch in Relieving Postoperative Pain After Laparoscopic Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05406947 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing Tiantan Hospital
- Last refreshed: 8 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05406947.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing